| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2009 | US20090054244 Nucleic acid molecule encoding a novel estrogen receptor beta variant |
| 02/26/2009 | US20090053828 Detection of glycopeptides and glycoproteins for medical diagnostics |
| 02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
| 02/26/2009 | US20090053821 Fluorescence quenching azo dyes, their methods of preparation and use |
| 02/26/2009 | US20090053807 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 02/26/2009 | US20090053791 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 02/26/2009 | US20090053790 Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053748 Cytochrome c protein and assay |
| 02/26/2009 | US20090053745 Methods and Kits for Regulation of Microtubule Assembly and Dendrite Growth and Branching |
| 02/26/2009 | US20090053742 Capture and release based isotope tagged peptides and methods for using the same |
| 02/26/2009 | US20090053739 Heme Binding Protein (HBP); use in drug screening agents that modulate FPRL2 (Formyl peptide receptor-like 2 ) |
| 02/26/2009 | US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 02/26/2009 | US20090053717 Methods and compositions for detecting spermatozoa or semen in a sample |
| 02/26/2009 | US20090053713 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 02/26/2009 | US20090053703 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/26/2009 | US20090053702 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/26/2009 | US20090053701 Detectable nucleic acid tag |
| 02/26/2009 | US20090053360 Gene encoding glycogen synthase and use thereof |
| 02/26/2009 | US20090053359 Ammonia transporter gene and use thereof |
| 02/26/2009 | US20090053358 Sulfate Ion Transporter Gene and Use Thereof |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053291 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 02/26/2009 | US20090053265 Antigenic peptides and their use |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053257 Replikin peptides and uses thereof |
| 02/26/2009 | US20090053255 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 02/26/2009 | US20090053254 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053237 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053228 Lawsonia intracellularis subunit vaccines |
| 02/26/2009 | US20090053223 Expression-enhanced polypeptides |
| 02/26/2009 | US20090053222 Inhibitors of CD200 such as antibodies or antisense agents for treating cancer, tumor, leukemia |
| 02/26/2009 | US20090053202 Peptide fragment of LYVE-1 and antibody against the same |
| 02/26/2009 | US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides |
| 02/26/2009 | US20090053194 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 02/26/2009 | US20090053177 Protein-polymer conjugates |
| 02/26/2009 | US20090053173 Stabilization of such as human interleukin 11; reduced toxicity; cost effective; shelf life; SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma; between a human serum albumin and an Interferon |
| 02/26/2009 | US20090053167 C-, S- and N-glycosylation of peptides |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells |
| 02/26/2009 | US20090051071 Dielectric substance and method of producing the same |
| 02/26/2009 | CA2707840A1 Amino acid substituted molecules |
| 02/26/2009 | CA2697252A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | CA2697049A1 Composition and methods of making and using influenza proteins |
| 02/26/2009 | CA2697032A1 Activatable binding polypeptides and methods of identification and use thereof |
| 02/26/2009 | CA2696865A1 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 02/26/2009 | CA2696864A1 New proteins for use in human and animal staphylococcus infections |
| 02/26/2009 | CA2696761A1 Human c-fms antigen binding proteins |
| 02/26/2009 | CA2696691A1 Hypoallergenic molecules |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | CA2696627A1 Psma binding ligand-linker conjugates and methods for using |
| 02/26/2009 | CA2696591A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | CA2696580A1 Collagen-containing cell carrier |
| 02/26/2009 | CA2696363A1 Method for purifying or detecting a target protein |
| 02/26/2009 | CA2696208A1 Treatment with kallikrein inhibitors |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | CA2694854A1 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| 02/26/2009 | CA2693361A1 Process |
| 02/25/2009 | EP2028493A1 Procalcitonin 3-116 |
| 02/25/2009 | EP2028275A2 Protein glycosylation modification in pichia pastoris |
| 02/25/2009 | EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof |
| 02/25/2009 | EP2028266A1 Method of producing lymphocytes |
| 02/25/2009 | EP2028192A1 GLP-1 and methods for treating diabetes |
| 02/25/2009 | EP2028191A1 Peptides and compounds that bind to a receptor |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028189A2 Variants of group 1 allergens made of poaceae with reduced allergenicity and received T-cell reactivity |
| 02/25/2009 | EP2028188A1 Hypoallergenic molecules |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027875A1 A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC) |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027296A2 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 02/25/2009 | EP2027276A2 Antifungal polypeptides |
| 02/25/2009 | EP2027274A1 Modified vird2 protein and its use in improved gene transfer |
| 02/25/2009 | EP2027271A2 Recombinant vectors |
| 02/25/2009 | EP2027157A2 Modified humanised anti-interleukin-18 antibodies |
| 02/25/2009 | EP2027152A2 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 02/25/2009 | EP2027151A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 02/25/2009 | EP2027150A1 Allorestricted peptide-specific t cells |
| 02/25/2009 | EP2027149A1 House dust mite allergen |
| 02/25/2009 | EP2027148A2 Chymotrypsin from lucilia sericata larvae and its use for the treatment of wounds |
| 02/25/2009 | EP2027147A1 Phl p 1 allergen derivative |
| 02/25/2009 | EP2027146A2 Replikin peptides and uses thereof |
| 02/25/2009 | EP2027145A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof |
| 02/25/2009 | EP2026838A2 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 02/25/2009 | EP2026837A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 02/25/2009 | EP2026836A2 Peptide therapy |
| 02/25/2009 | EP2026830A2 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis |
| 02/25/2009 | EP1945660A4 Library from toxin mutants, and methods of using same |
| 02/25/2009 | EP1893635A4 Anchored transferrin fusion protein libraries |
| 02/25/2009 | EP1711519B1 Proteins inducing multiple resistance of plants to phytopathogens and pests |
| 02/25/2009 | EP1301795B1 Method of identifying and/or isolating stem cells |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/25/2009 | EP0906448B1 Methods for the diagnosis and prognosis of cancer |